Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain activation during memory tasks in patients with schizophrenia treated with ziprasidone or risperidone (fMRI study)
2004-004482-15Phase 4Terminated
- Sponsor
- University Hospital RWTH Aachen
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ziprasidone and risperidone in schizophrenia (2 arms), sponsored by University Hospital RWTH Aachen. Primary endpoint: BOLD effect in the brain. Started Jan 2006; status: terminated.
02
Drugs
ziprasidonerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-004482-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004482-15.